Table 2 Multivariate analysis for factors associated with off-treatment sustained virologic suppression
Factors | Odds ratio (95% CI) | P-value |
|---|---|---|
HBeAg positivity | 1.43 (0.44–4.67) | 0.554 |
Medication (lamivudine/clevudine vs. entecavir) | 2.19 (0.66–7.20) | 0.198 |
Total treatment (months) | 64.20 (1.17–3530.37) | 0.042 |